CBDL (CBD Life Sciences) FCF Margin %: 0.00% (As of Sep. 2015)


What is CBD Life Sciences FCF Margin %?

CBD Life Sciences CBDL -16.67% FCF Margin % is 0.00% as of Sep. 2015.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. CBD Life Sciences's Free Cash Flow for the three months ended in Sep. 2015 was $0.00 Mil. CBD Life Sciences's Revenue for the three months ended in Sep. 2015 was $0.00 Mil. Therefore, CBD Life Sciences's FCF Margin % for the quarter that ended in Sep. 2015 was 0.00%.

As of today, CBD Life Sciences's current FCF Yield % is -28.32%.

The historical rank and industry rank for CBD Life Sciences's FCF Margin % or its related term are showing as below:

CBDL' s FCF Margin % Range Over the Past 10 Years
Min: -341.46   Med: 0   Max: 0
Current: -341.46

CBDL's FCF Margin % is not ranked
in the Drug Manufacturers industry.
Industry Median: 2.51 vs CBDL: -341.46

CBD Life Sciences FCF Margin % Related Terms

CBD Life Sciences FCF Margin % Historical Data

* Premium members only.

The historical data trend for CBD Life Sciences's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CBD Life Sciences FCF Margin % Chart

CBD Life Sciences Annual Data
Trend Dec11 Dec12 Dec13 Dec14
FCF Margin %
0.00 0.00 -312.18 -644.72

CBD Life Sciences Quarterly Data
Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -101.63 0.00 0.00 0.00

CBDL vs QPAG, ADGO, MCCX: FCF Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, CBD Life Sciences's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CBD Life Sciences FCF Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CBD Life Sciences's FCF Margin % distribution charts can be found below:

* The bar in red indicates where CBD Life Sciences's FCF Margin % falls into.


CBD Life Sciences FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

CBD Life Sciences's FCF Margin for the fiscal year that ended in Dec. 2014 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2014 )/Revenue (A: Dec. 2014 )
=-0.793/0.123
=-644.72 %

CBD Life Sciences's FCF Margin for the quarter that ended in Sep. 2015 is calculated as

FCF Margin=Free Cash Flow (Q: Sep. 2015 )/Revenue (Q: Sep. 2015 )
=0/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
CBD Life Sciences (CBDL) has a FCF Margin % of 0.00% as of Sep. 2015. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on CBD Life Sciences and its competitors.
Is CBD Life Sciences' FCF Margin % too high?
CBD Life Sciences' current FCF Margin % is 0.00%.
How does CBD Life Sciences' FCF Margin % compare to QPAG and ADGO?
CBD Life Sciences' FCF Margin % of 0.00% can be compared against companies in the Drug Manufacturers industry. The industry median FCF Margin % is 2.51. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.51, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on CBD Life Sciences and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CBD Life Sciences's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CBD Life Sciences stock overvalued right now?
CBD Life Sciences (CBDL) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For CBD Life Sciences (CBDL), the current FCF Margin % is 0.00% as of Sep. 2015. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CBD Life Sciences Business Description

Address 10953 N. Frank Llyod Wright Boulevard, Unit 108, Scottsdale, AZ, USA, 85259
CBD Life Sciences Inc is developing and marketing a line of cannabidiol-based organic products such as hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, and a full line of pet products.